Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Pigment-dispersion syndrome is an eye disorder that occurs when pigment granules that normally adhere to the back of the iris (the colored part of the eye) flake off into the clear fluid produced by the eye (aqueous humor). These pigment granules may flow towards the drainage canals of the eye, slowly clogging them and raising the pressure within the eye (intraocular pressure or IOP). This rise in eye pressure can cause damage to the optic nerve (the nerve in the back of the eye that carries visual images to the brain). If the optic nerve becomes damaged, pigment-dispersion syndrome becomes pigmentary glaucoma. This happens in about 30% of cases. Pigment-dispersion syndrome commonly presents between the second and fourth decades, which is earlier than other types of glaucoma. While men and women are affected in equal numbers, men develop pigmentary glaucoma up to 3 times more often than women. Myopia (nearsightedness) appears to be an important risk factor in the development of pigment-dispersion syndrome and is present in up to 80% of affected individuals. The condition may be sporadic or follow an autosomal dominant pattern of inheritance with reduced penetrance. At least one gene locus on chromosome 7 has been identified. Pigment-dispersion syndrome can be treated with eye drops or other medications. In some cases, laser surgery may be performed.
Features include: Open angle glaucoma, Damage to the optic nerve (optic atrophy), and Myopia.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 2 | Open angle glaucoma, Damage to the optic nerve (optic atrophy) |
Muscles |
No clinical trials have been registered for pigment dispersion syndrome.
24 publications have been identified in PubMed for pigment dispersion syndrome. Research spans Case Report / Case Series (46%), Epidemiology / Natural History (17%), and Review / Meta-Analysis (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 11 | 46% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 3:02 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
1
Damage to the optic nerve (optic atrophy) |
4 |
17% |
Research summaries | 3 | 13% |
Other research | 2 | 8% |
Clinical study results | 2 | 8% |
Laboratory research | 2 | 8% |
Skowronski A (2026). [PMID: 42154262](https://pubmed.ncbi.nlm.nih.gov/42154262/). *Ophthalmologie*. [Review / Meta-Analysis]
Tomczyk-Socha M (2026). [PMID: 41598529](https://pubmed.ncbi.nlm.nih.gov/41598529/). *J Clin Med*. [Review / Meta-Analysis]
Gurnani B (2026). [PMID: 35593834](https://pubmed.ncbi.nlm.nih.gov/35593834/). *Unknown Journal*. [Other]
Chau HT (2026). [PMID: 41410077](https://pubmed.ncbi.nlm.nih.gov/41410077/). *Pharmacol Res Perspect*. [Epidemiology / Natural History]
Kolovos A (2026). [PMID: 41130539](https://pubmed.ncbi.nlm.nih.gov/41130539/). *Ophthalmol Glaucoma*. [Basic Science / Preclinical]
Zeppieri M (2026). [PMID: 35593820](https://pubmed.ncbi.nlm.nih.gov/35593820/). *Unknown Journal*. [Other]
Lozano-Arriaga D (2025). [PMID: 40802212](https://pubmed.ncbi.nlm.nih.gov/40802212/). *Int Ophthalmol*. [Epidemiology / Natural History]
Kayarian FB (2025). [PMID: 40711400](https://pubmed.ncbi.nlm.nih.gov/40711400/). *Ophthalmic Surg Lasers Imaging Retina*. [Case Report / Case Series]
Radmilović M (2025). [PMID: 40868812](https://pubmed.ncbi.nlm.nih.gov/40868812/). *Life (Basel)*. [Case Report / Case Series]
Shah P (2025). [PMID: 39508410](https://pubmed.ncbi.nlm.nih.gov/39508410/). *Curr Opin Ophthalmol*. [Review / Meta-Analysis]